Neuroticism, conscientiousness, and in vivo Alzheimer pathologies measured by amyloid PET and MRI
- PMID: 31985106
- DOI: 10.1111/pcn.12983
Neuroticism, conscientiousness, and in vivo Alzheimer pathologies measured by amyloid PET and MRI
Abstract
Aim: It has been suggested that personality traits, particularly neuroticism and conscientiousness, are risk factors for Alzheimer's disease (AD) and related cognitive decline. However, the underlying pathological links between personality traits and AD-related cognitive impairments remain unclear. Thus, the present study investigated associations of neuroticism and conscientiousness with in vivo cerebral amyloid-beta (Aβ) burden, AD-signature regional neurodegeneration, and white matter hyperintensities (WMH) in non-demented middle- and old-aged adults.
Methods: A total of 397 non-demented participants underwent comprehensive clinical and neuropsychological assessments, 11 C-labeled Pittsburgh Compound B positron emission tomography, and magnetic resonance imaging. Additionally, the NEO Five-Factor Inventory was administered to both the participants and their informants to measure neuroticism and conscientiousness.
Results: Neither neuroticism nor conscientiousness was associated with cerebral Aβ deposition or WMH. In contrast, higher neuroticism and lower conscientiousness, reported by informants in particular, were significantly associated with reduced AD-signature region cortical thickness. In regards to the direct and indirect effect of each personality on AD-signature region cortical thickness, only the direct effects were found, whereas indirect effects via Aβ deposition or WMH were not.
Conclusion: The present findings suggest that amyloid-independent regional neurodegeneration might underlie relations of neuroticism and conscientiousness with AD.
Keywords: Alzheimer's disease; beta-amyloid; conscientiousness; neurodegeneration; neuroticism.
© 2020 The Authors. Psychiatry and Clinical Neurosciences © 2020 Japanese Society of Psychiatry and Neurology.
Similar articles
-
Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.Alzheimers Dement. 2024 Jun;20(6):3931-3942. doi: 10.1002/alz.13845. Epub 2024 Apr 22. Alzheimers Dement. 2024. PMID: 38648354 Free PMC article.
-
Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.Curr Alzheimer Res. 2015;12(6):563-71. doi: 10.2174/1567205012666150530202124. Curr Alzheimer Res. 2015. PMID: 26027813
-
Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study.PLoS Med. 2020 Feb 25;17(2):e1003022. doi: 10.1371/journal.pmed.1003022. eCollection 2020 Feb. PLoS Med. 2020. PMID: 32097439 Free PMC article.
-
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Semin Nucl Med. 2011. PMID: 21624562 Review.
-
The Role of Amyloid-β in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases.J Alzheimers Dis. 2020;78(1):13-22. doi: 10.3233/JAD-200868. J Alzheimers Dis. 2020. PMID: 32925075 Review.
Cited by
-
Personality and neuropsychiatric symptoms in individuals diagnosed with long COVID.BMC Infect Dis. 2024 Dec 19;24(1):1449. doi: 10.1186/s12879-024-10308-0. BMC Infect Dis. 2024. PMID: 39702051 Free PMC article.
-
Circadian rest-activity rhythm and longitudinal brain changes underlying late-life cognitive decline.Psychiatry Clin Neurosci. 2023 Apr;77(4):205-212. doi: 10.1111/pcn.13521. Epub 2023 Jan 4. Psychiatry Clin Neurosci. 2023. PMID: 36527292 Free PMC article.
-
Personality Associations With Amyloid and Tau: Results From the Baltimore Longitudinal Study of Aging and Meta-analysis.Biol Psychiatry. 2022 Feb 15;91(4):359-369. doi: 10.1016/j.biopsych.2021.08.021. Epub 2021 Sep 3. Biol Psychiatry. 2022. PMID: 34663503 Free PMC article.
-
Serum Adiponectin and In Vivo Brain Amyloid Deposition in Cognitively Normal Older Adults: A Cohort Study.Aging Dis. 2023 Jun 1;14(3):904-918. doi: 10.14336/AD.2022.1118. Aging Dis. 2023. PMID: 37191420 Free PMC article.
-
The association between personality and plasma biomarkers of astrogliosis and neuronal injury.Neurobiol Aging. 2023 Aug;128:65-73. doi: 10.1016/j.neurobiolaging.2023.04.011. Epub 2023 Apr 25. Neurobiol Aging. 2023. PMID: 37210782 Free PMC article.
References
-
- Matthews G, Deary IJ, Whiteman MC. Personality Traits. Cambridge University Press, Cambridge, 2009.
-
- Terracciano A, Sutin AR, An Y et al. Personality and risk of Alzheimer's disease: New data and meta-analysis. Alzheimers Dement. 2014; 10: 179-186.
-
- Low LF, Harrison F, Lackersteen SM. Does personality affect risk for dementia? A systematic review and meta-analysis. Am. J. Geriatr. Psychiatry 2013; 21: 713-728.
-
- Wilson RS, Schneider JA, Arnold SE, Bienias JL, Bennett DA. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch. Gen. Psychiatry 2007; 64: 1204-1212.
-
- Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 2004; 127: 601-609.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical